1-6 of 6
Luigi Manenti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB284: CLAUDIN-1 targeting antibody ALE.C04 drives single activity and restores anti-PD1 efficacy in solid tumors

Alberto Toso, Geoffrey Teixeira, Tina Zimmermann, Stefanie Gill Gill, Daniela Schmitter, Markus Meyer, Marion Muller, Laurent Mailly, Thomas Baumert, Luigi Manenti, Roberto Iacone
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): LB284.
https://doi.org/10.1158/1538-7445.AM2023-LB284
Published: 14 April 2023
View article titled, Abstract LB284: CLAUDIN-1 targeting antibody ALE.C04 drives single activity and restores anti-PD1 efficacy in solid tumors
Journal Articles

Abstract LB012: Claudin-1 is a driver and therapeutic target for cholangiocarcinoma

Marion Muller, Zeina Nehme, Emilie Crouchet, Frank Jühling, Natascha Röhlen, Patrick Pessaux, Emanuele Felli, Lipika Goyal, Markus Meyer, Roberto Iacone, Alberto Toso, Luigi Manenti, Patrice Laquerriere, Aïna Venkatasamy, Nabeel Bardeesy, Catherine Schuster, Laurent Mailly, Thomas F. Baumert
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): LB012.
https://doi.org/10.1158/1538-7445.AM2023-LB012
Published: 14 April 2023
View article titled, Abstract LB012: Claudin-1 is a driver and therapeutic target for cholangiocarcinoma
Journal Articles

Abstract CT150: Phase II study of spartalizumab (PDR001) vs chemotherapy (CT) in patients with recurrent/metastatic nasopharyngeal cancer (NPC)

Darren Wan-Teck Lim, Hung-Ming Wang, Shau-Hsuan Li, Roger Ngan, Arunee Dechaphunkul, Li Zhang, Chia Jui Yen, Po Chung Chan, Somvilai Chakrabandhu, Brigette Ma, Suebpong Tanasanvimon, Victor Lee, Pei-Jen Lou, Zujun Li, Alexander Spira, Ammar Sukari, Joël Guigay, Steven McCune, Yongjian Sun, Sebastian Szpakowski, Yao Yao, Xueqiang Fan, Luigi Manenti, Caroline Even
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT150.
https://doi.org/10.1158/1538-7445.AM2019-CT150
Published: 01 July 2019
View article titled, Abstract CT150: Phase II study of spartalizumab (PDR001) vs chemotherapy (CT) in patients with recurrent/metastatic nasopharyngeal cancer (NPC)
Journal Articles

Abstract CT183: Phase (Ph) I/II study of MBG453± spartalizumab (PDR001) in patients (pts) with advanced malignancies

Giuseppe Curigliano, Hans Gelderblom, Nicolas Mach, Toshihiko Doi, Wai Meng David Tai, Patrick Forde, John Sarantopoulos, Philippe L. Bedard, Chia-Chi Lin, Stephen Hodi, Sofie Wilgenhof, Armando Santoro, Catherine Sabatos-Peyton, Tyler Longmire, Kitty Wan, Panagiotis Nikolopoulos, Luigi Manenti, Aung Naing
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT183.
https://doi.org/10.1158/1538-7445.AM2019-CT183
Published: 01 July 2019
View article titled, Abstract CT183: Phase (Ph) I/II study of MBG453± spartalizumab (PDR001) in patients (pts) with advanced malignancies
Journal Articles

Abstract LB-220: Translational research with RG7160 (GA201) leads to a phase II clinical study in combination with FOLFIRI in 2nd line metastatic colorectal cancer (mCRC)

Andrés Cervantes, Ben Markman, Salvatore Siena, Carles Pericay, Giuseppe Aprile, John Bridgewater, Antonio Cubillo, Ashita Waterston, Luis Paz Ares, Jean-Charles Soria, Stephane Temam, David Oppenheim, Jon Chick, David Carlile, Sophie Golding, Maria Longauer Banholzer, Alexandre Passioukov, Chrstian Gerdes, Sophia Soehrman, Christoph Mancao, Luigi Manenti, Josep Tabernero
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): LB-220.
https://doi.org/10.1158/1538-7445.AM2012-LB-220
Published: 15 April 2012
View article titled, Abstract LB-220: Translational research with RG7160 (GA201) leads to a phase II clinical study in combination with FOLFIRI in 2<sup>nd</sup> line metastatic colorectal cancer (mCRC)
Journal Articles

Matrix Metalloproteinases (MMP9 and MMP2) Induce the Release of Vascular Endothelial Growth Factor (VEGF) by Ovarian Carcinoma Cells: Implications for Ascites Formation

Dorina Belotti, Paola Paganoni, Luigi Manenti, Angela Garofalo, Sergio Marchini, Giulia Taraboletti, Raffaella Giavazzi
Journal: Cancer Research
Cancer Res (2003) 63 (17): 5224–5229.
Published: 18 September 2003
View article titled, Matrix Metalloproteinases (MMP9 and MMP2) Induce the Release of Vascular Endothelial Growth Factor (VEGF) by Ovarian Carcinoma Cells: <subtitle>Implications for Ascites Formation</subtitle>
Open the PDF for Matrix Metalloproteinases (MMP9 and MMP2) Induce the Release of Vascular Endothelial Growth Factor (VEGF) by Ovarian Carcinoma Cells: <subtitle>Implications for Ascites Formation</subtitle> in another window